Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Milestone - RE: Why would TPL want to merge with PTSC?

Milestone - RE: Why would TPL want to merge with PTSC?

posted on May 08, 2006 12:30PM
Yes, but if they do, they get 100% of the portfolio, control and development of the Ignite and any remaining tax credits we have...some elements of greed.

Key to it all is being able to measure what Ignite would bring to the table, and what type of relationship would be in existence with their Licensed customers? If analysis showed market demand for an Ignite solution was strong, so strong that PTSC`s warts might be worth it...wouldn`t that alter the way TPL viewed the company?

Question is, do the benefits of total owership outweight the associated headaches? And whose to say later we could be removed from the equation?...just about nothing` permanent

Too much time on my hands today, asking these types of questions.

Regards

Share
New Message
Please login to post a reply